✦ LIBER ✦

Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience

✍ Scribed by Burkes, Ronald L.; Ginsberg, Robert J.; Shepherd, Frances A.; Blackstein, Martin E.; Goldberg, Melvyn E.; Waters, Paul F.; Alexander Patterson, G.; Todd, Thomas; Griffith Pearson, F.; Cooper, Joel D.; Jones, Donald; Lockwood, Gina

Book ID: 122900215
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 464 KB
Volume: 9
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(93)90694-S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction chemotherapy with MVP (mitomyc

Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: The Toronto experience

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Induction chemotherapy with MVP in patie

Induction chemotherapy with MVP in patients with stage IIIA (T1–3,N2,M0) unresectable non-small cell lung cancer (NSCLC): The Toronto experience

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Induction chemotherapy with mitomycin, v

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial

✍ Burkes, Ronald L.; Shepherd, Frances A.; Blackstein, Martin E.; Goldberg, Melvin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Induction chemotherapy with mitomycin, v

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: Results of the Toronto phase II trial

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase II trial of individualized respo

A phase II trial of individualized response-based induction chemotherapy (IC) of mitomycin-C, vindesine, cisplatin (MVP) followed by thoracic radiotherapy (TRT) with daily low-dose carboplatin (CBDCA) for the treatment of unresectable stage III non-small-cell lung cancer (NSCLC)

✍ Shinbo, T; Makino, M; Tsukada, H; Yokoyama, A; Saitou, M; Kurita, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 230 KB

The Role of Consolidation Therapy for St

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy

✍ Arya Amini; Arlene M. Correa; Ritsuko Komaki; Joe Y. Chang; Anne S. Tsao; Jack A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 489 KB